Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T23:03:13.506Z Has data issue: false hasContentIssue false

Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review

Published online by Cambridge University Press:  19 February 2008

N A Khalidi*
Affiliation:
Section of Rheumatology, McMaster University, Hamilton, Ontario, Canada
R Rebello
Affiliation:
Section of Radiology, McMaster University, Hamilton, Ontario, Canada
D D Robertson
Affiliation:
Section of ENT, McMaster University, Hamilton, Ontario, Canada
*
Address for correspondence: Dr Nader Khalidi, Section of Rheumatology, McMaster University, 240 James St South, Hamilton, Ontario, CanadaL8P 3B3. Fax: 905 521 8099 E-mail: [email protected]

Abstract

Objectives:

We present a case of systemic lupus erythematosus with symptomatic sensorineural hearing loss which was successfully treated with azathioprine, as assessed both clinically and radiologically. We also present a review of the relevant literature.

Case report:

A woman with systemic lupus erythematosus presented with sensorineural hearing loss, initially on the right and subsequently developing on the left over several months. An audiogram revealed profound neurosensory hearing loss bilaterally. The patient was treated with prednisone 60 mg daily and azathioprine 200 mg daily. An improvement on the left was noted on follow-up audiography as well as on magnetic resonance imaging of the internal auditory canals and surrounding structures.

Conclusion:

Sensorineural hearing loss has been described in autoimmune disorders but is rare. Aural symptoms have been described, with varying incidences (0–57.5 per cent), in systemic lupus erythematosus. However, symptomatic sensorineural hearing loss is rare in systemic lupus erythematosus. Prednisone appears essential when an immunological or vasculitic cause is found. The use of azathioprine should be considered, as well as follow-up with magnetic resonance imaging to detect improvement.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Sheehy, J. Doctor's discussion. Am J Otolaryngol 1981;20:405–7Google Scholar
2Hamblin, TJ, Mufti, GJ, Bracewell, A. Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange. Br Med J (Clin Res Ed) 1982;284:1374CrossRefGoogle ScholarPubMed
3Caldarelli, DD, Rejowski, JE, Corey, JP. Sensorineural hearing loss in lupus erythematosus. Am J Otol 1986;7:210–13Google ScholarPubMed
4Bowman, CA, Linthicum, FH Jr, Nelson, RA, Mikami, K, Quismorio, F. Sensorineural hearing loss associated with systemic lupus erythematosus. Otolaryngol Head Neck Surg 1986;94:197204CrossRefGoogle ScholarPubMed
5Narula, AA, Powell, RJ, Davis, A. Frequency-resolving ability in systemic lupus erythematosus. Br J Audiol 1989;23:6972Google Scholar
6Andonopoulos, AP, Naxakis, S, Goumas, P, Lygatsikas, C. Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin Exp Rheumatol 1995;13:137–41Google Scholar
7Sperling, NM, Tehrani, K, Liebling, A, Ginzler, E. Aural symptoms and hearing loss in patients with lupus. Otolaryngol Head Neck Surg 1998;118:762–5Google Scholar
8Johansen, PB, Gran, JT. Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 1998;16:472–4Google Scholar
9Naarendorp, M, Spiera, H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J Rheumatol 1998;25:589–92Google ScholarPubMed
10Sone, M, Schachern, PA, Paparella, MM, Morizono, N. Study of systemic lupus erythematosus in temporal bones. Ann Otol Rhinol Laryngol 1999;108:338–44Google Scholar
11Peeva, E, Barland, P. Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus. Scand J Rheumatol 2001;30:45–7Google ScholarPubMed
12Kastanioudakis, I, Ziavra, N, Voulgari, PV, Exarchakos, G, Skevas, A, Drosos, AA. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 2002;116:103–7CrossRefGoogle ScholarPubMed
13Karatas, E, Onat, AM, Durucu, C, Baglam, T, Kanlikama, M, Altunoren, O et al. Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 2007;136:82–6CrossRefGoogle ScholarPubMed
14Wang, C, Fortin, PR, Li, Y, Panaritis, T, Gans, M, Esdaile, JM. Discontinuation of antimalarial drugs in systemic lupus erythematosus. J Rheumatol 1999;26:808–15Google Scholar
15Salley, LH Jr, Grimm, M, Sismanis, A, Spencer, RF, Wise, CM. Methotrexate in the management of immune mediated cochleovestibular disorders: clinical experience with 53 patients. J Rheumatol 2001;28:1037–40Google ScholarPubMed
16Loveman, DM, Comarmond, CDe, Cepero, R, Baldwin, DM. Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin Arthritis Rheum 2004;34:538–43CrossRefGoogle ScholarPubMed
17Roverano, S, Cassano, G, Paira, S, Chiavarini, J, Graf, C, Rico, L. et al. Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus. J Clin Rheumatol 2006;12:217–20Google Scholar
18Paira, SO. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies. J Rheumatol 1998;25:2476–7Google ScholarPubMed
19Compadretti, GC, Brandolini, C, Tasca, I. Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review. Ann Otol Rhinol Laryngol 2005;114:214–18Google Scholar
20Green, L, Miller, EB. Sudden sensorineural hearing loss as a first manifestation of systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Rheumatol 2001;20:220–2Google Scholar
21McCabe, BF. Autoimmune inner ear disease: therapy. Am J Otol 1989;10:196–7Google ScholarPubMed
22McCabe, BF. Autoimmune inner ear disease: results of therapy. Adv Otorhinolaryngol 1991;46:7881Google Scholar
23Hughes, GB, Kinney, SE, Barna, BP, Calabrese, LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope 1984;94:758–67Google Scholar
24Cotter, CS, Singleton, GT, Corman, LC. Immune-mediated inner ear disease and parvovirus B19. Laryngoscope 1994;104:1235–9Google Scholar
25Sismanis, A, Wise, CM, Johnson, GD. Methotrexate management of immune-mediated cochleovestibular disorders. Otolaryngol Head Neck Surg 1997;116:146–52Google ScholarPubMed
26Matteson, EL, Fabry, DA, Facer, GW, Beatty, CW, Driscoll, CL, Strome, SE et al. Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Rheum 2001;45:146–50Google Scholar
27Kilpatrick, JK, Sismanis, A, Spencer, RF, Wise, CM. Low-dose oral methotrexate management of patients with bilateral Meniere's disease. Ear Nose Throat J 2000;79:82–8,91Google Scholar
28Harris, JP, Weisman, MH, Derebery, JM, Espeland, MA, Gantz, BJ, Gulya, AJ et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003;290:1875–83Google Scholar
29Broughton, SS, Meyerhoff, WE, Cohen, SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 2004;34:544–8Google Scholar
30Saracaydin, A, Katircioglu, S, Katircioglu, S, Karatay, MC. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease. J Int Med Res 1993;21:192–6Google Scholar
31Pyykko, I, Ishizaki, H, Peltomaa, M. Azathioprine with cortisone in treatment of hearing loss in only hearing ear. Acta Otolaryngol Suppl 1997;529:83–5Google Scholar
32Hisashi, K, Komune, S, Taira, T, Uemura, T, Sadoshima, S, Tsuda, H. Anticardiolipin antibody-induced sudden profound sensorineural hearing loss. Am J Otolaryngol 1993;14:275–7Google Scholar